Abstract
When The jungle was published in 1905 in the United States the general public became aware of the deplorable and filthy conditions in Chicago slaughterhouses [1]. The exposé was written as a social comment about the manner in which the industry treated its employees rather than as an indictment of the unwholesomeness of packed meats. Although deaths caused by consuming infected meat were described, Sinclair’s targets were the pitiful living conditions of the workers and their families and the greed of the packing plant owners. The book is widely credited for causing the passage of the Federal Food, Drug and Liquor Act of 1906. The key provision of this act required manufacturers to label their products accurately.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Sinclair U. The jungle. Cambridge, MA, Robert Bently, Inc. 1905.
Timm EA. 75 Years compliance with biological product regulations. Food Drug Cosmetic Law J 1978;33:225–30.
FDA brings injunction against prescription drug manufacturer. CCBC Newsletter. Washington, CCBC, 1993;August 20:1.
Polesky HF. Should blood banks institute GMPs? Continues flow. Baxter, Deerfield, IL, 1993;Jan-Feb:4,8.
Menitove JE. The recent emphasis on good manufacturing practices and the pharmaceutical manufacturing approach damages blood banking and transfusion medicine as medical care activities. Transfusion 1993;33:439–42.
Laffel G, Blumenthal D. The case of using industrial quality management science in health care organizations. JAMA 1989;262:2869–73.
Anderson K. Should blood banks institute GMPs? Continuous flow. Baxter, Deerfield, IL, 1993;Jan-Feb:8,10.
Kritchevsky SB, Simmons BP. Continuous quality improvement. JAMA 1991;266: 1817–23.
Miller WV. Blood banks should use good manufacturing practices and the pharmaceutical manufacturing approach. Transfusion 1993;33:435–8.
Deming WE. Out of the crisis. Massachusetts Institute of Technology, Center for Advanced Engineering Study, Cambridge, MA, 1986.
Blood manufacturers must act more like drug manufacturers. CCBC Newsletter, Washington, CCBC 1993;July 30:1.
Train-the-trainer manual. CCBC and Ortho Diagnostic System, Washington and Raritanl991.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Zuck, T.F. (1994). The Good Manufacturing Practice Concept. In: Sibinga, C.T.S., Das, P.C., Heiniger, H.J. (eds) Good Manufacturing Practice in Transfusion Medicine. Developments in Hematology and Immunology, vol 29. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2608-7_4
Download citation
DOI: https://doi.org/10.1007/978-1-4615-2608-7_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6117-6
Online ISBN: 978-1-4615-2608-7
eBook Packages: Springer Book Archive